Icure Pharmaceutical Incorporation (KOSDAQ:175250)

KOSDAQ:175250 Revenue

In the year 2025, Icure Pharmaceutical Incorporation had annual revenue of 83.38B KRW with 64.45% growth.

• Revenue: 83.38B
• Revenue Growth: +64.45%
• P/S Ratio: 0.97
• Revenue / Employee: 379.02M
• Employees: 220
• Market Cap: 81.09B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	83.38B	32.68B	64.45%
Dec 31, 2024	50.71B	-6.10B	-10.74%
Dec 31, 2023	56.81B	-2.56B	-4.31%
Dec 31, 2022	59.37B	-4.92B	-7.65%
Dec 31, 2021	64.28B	-25.86B	-28.69%